175 related articles for article (PubMed ID: 18317865)
1. Triptans in the Italian population: a drug utilization study and a literature review.
Panconesi A; Pavone E; Vacca F; Vaiani M; Banfi R
J Headache Pain; 2008 Apr; 9(2):71-6. PubMed ID: 18317865
[TBL] [Abstract][Full Text] [Related]
2. Triptans: low utilization and high turnover in the general population.
Panconesi A; Pavone E; Franchini M; Mennuti N; Bartolozzi M; Guidi L; Banfi R
Cephalalgia; 2010 May; 30(5):576-81. PubMed ID: 19732070
[TBL] [Abstract][Full Text] [Related]
3. Patterns of triptans use: a study based on the records of a community pharmaceutical department.
Pavone E; Banfi R; Vaiani M; Panconesi A
Cephalalgia; 2007 Sep; 27(9):1000-4. PubMed ID: 17681022
[TBL] [Abstract][Full Text] [Related]
4. Health care resource utilization following initiation of a triptan: a retrospective claims analysis.
Messali A; Owens G; Bloudek L; Kori S; Cole A; Chia J
J Manag Care Spec Pharm; 2014 Apr; 20(4):368-75. PubMed ID: 24684641
[TBL] [Abstract][Full Text] [Related]
5. Utilisation of prescription and over-the-counter triptans: a cross-sectional study in Stockholm, Sweden.
Frisk P; Sporrong SK; Ljunggren G; Wettermark B; von Euler M
Eur J Clin Pharmacol; 2016 Jun; 72(6):747-54. PubMed ID: 26922586
[TBL] [Abstract][Full Text] [Related]
6. Geographic variation in the use of triptans and opioids for the acute treatment of migraine attacks.
Lee JH; Shewale AR; Barthold D; Devine B
Headache; 2021 Nov; 61(10):1499-1510. PubMed ID: 34841520
[TBL] [Abstract][Full Text] [Related]
7. Patterns of use and health expenses associated with triptans among adults with migraines.
Wu J; Noxon V; Lu ZK
Clin J Pain; 2015 Aug; 31(8):673-9. PubMed ID: 25185875
[TBL] [Abstract][Full Text] [Related]
8. Utilization of triptans in Sweden; analyses of over the counter and prescription sales.
von Euler M; Keshani S; Baatz K; Wettermark B
Pharmacoepidemiol Drug Saf; 2014 Dec; 23(12):1288-93. PubMed ID: 25044442
[TBL] [Abstract][Full Text] [Related]
9. Triptans use and overuse: A pharmacoepidemiology study from the French health insurance system database covering 4.1 million people.
Braunstein D; Donnet A; Pradel V; Sciortino V; Allaria-Lapierre V; Lantéri-Minet M; Micallef J
Cephalalgia; 2015 Nov; 35(13):1172-80. PubMed ID: 25667299
[TBL] [Abstract][Full Text] [Related]
10. Triptan use in Italy: Insights from administrative databases.
Da Cas R; Nigro A; Terrazzino S; Sances G; Viana M; Tassorelli C; Nappi G; Cargnin S; Pisterna A; Traversa G; Genazzani AA
Cephalalgia; 2015 Jun; 35(7):619-26. PubMed ID: 25246521
[TBL] [Abstract][Full Text] [Related]
11. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
Ng-Mak DS; Chen YT; Ho TW; Stanford B; Roset M
Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
[TBL] [Abstract][Full Text] [Related]
12. Trends and prescribing patterns of antimigraine medicines in nine major cities in China from 2018 to 2022: a retrospective prescription analysis.
Huang J; Wang X; Jin Y; Lou G; Yu Z
J Headache Pain; 2024 Apr; 25(1):62. PubMed ID: 38654177
[TBL] [Abstract][Full Text] [Related]
13. Triptan use and risk of cardiovascular events: a nested-case-control study from the French health system database.
Lugardon S; Roussel H; Sciortino V; Montastruc JL; Lapeyre-Mestre M
Eur J Clin Pharmacol; 2007 Aug; 63(8):801-7. PubMed ID: 17576547
[TBL] [Abstract][Full Text] [Related]
14. Prescribing for migraine with the focus on selective 5HT1-receptor agonists: a pharmacy database analysis.
Truter I
Int J Clin Pharmacol Ther; 2010 May; 48(5):319-26. PubMed ID: 20420788
[TBL] [Abstract][Full Text] [Related]
15. Pattern of triptan use and cardiovascular coprescription: a pharmacoepidemiological study in Italy.
Biagi C; Poluzzi E; Roberto G; Puccini A; Vaccheri A; D'Alessandro R; Motola D; Montanaro N
Eur J Clin Pharmacol; 2011 Dec; 67(12):1283-9. PubMed ID: 21674159
[TBL] [Abstract][Full Text] [Related]
16. Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database - A cohort study.
Zebenholzer K; Gall W; Gleiss A; Pavelic AR; Wöber C
Headache; 2022 May; 62(5):604-612. PubMed ID: 35593784
[TBL] [Abstract][Full Text] [Related]
17. Identifying the factors underlying discontinuation of triptans.
Wells RE; Markowitz SY; Baron EP; Hentz JG; Kalidas K; Mathew PG; Halker R; Dodick DW; Schwedt TJ
Headache; 2014 Feb; 54(2):278-89. PubMed ID: 24001117
[TBL] [Abstract][Full Text] [Related]
18. Perinatal use of triptans and other drugs for migraine-A nationwide drug utilization study.
Tauqeer F; Wood M; Hjorth S; Lupattelli A; Nordeng H
PLoS One; 2021; 16(8):e0256214. PubMed ID: 34424941
[TBL] [Abstract][Full Text] [Related]
19. [Patterns of prescription and usage of triptans in Alsace (France): misuse is frequent and avoidable].
Perearnau P; Vuillemet F; Schick J; Weill G
Rev Neurol (Paris); 2006 Mar; 162(3):347-57. PubMed ID: 16585890
[TBL] [Abstract][Full Text] [Related]
20. Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response.
Marcus SC; Shewale AR; Silberstein SD; Lipton RB; Young WB; Viswanathan HN; Doshi JA
Cephalalgia; 2020 Jun; 40(7):639-649. PubMed ID: 32223301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
